Here’s our fortnightly wrap of all the news driving ASX health stocks.

Of the ASX’s 133-odd small cap health stocks and of those which were trading on Wednesday, 90 were in positive territory over the last fortnight, 13 were flat and 33 saw their share prices fall.

Code Name Price $ (August 19) 2 week return % 1 year return % Market cap
FTT FACTOR THERAPEUTICS LTD 0.005 67 67 $5,214,178
NTI NEUROTECH INTERNATIONAL LTD 0.016 60 -6 $3,959,450
IBX IMAGION BIOSYSTEMS LTD 0.081 60 75 $71,641,960
KZA KAZIA THERAPEUTICS LTD 0.83 59 134 $77,570,664
CDX CARDIEX LTD 0.055 57 139 $46,073,580
BNO BIONOMICS LTD 0.12 57 192 $65,749,516
BPH BPH ENERGY LTD 0.032 45 234 $13,951,561
RHY RHYTHM BIOSCIENCES LTD 0.115 44 -27 $16,648,938
ANR ANATARA LIFESCIENCES LTD 0.2 41 -17 $9,472,674
CPH CRESO PHARMA LTD 0.041 35 -90 $15,388,018
ATH ALTERITY THERAPEUTICS LTD 0.062 35 114 $67,270,248
UBI UNIVERSAL BIOSENSORS INC-CDI 0.325 30 63 $57,710,852
PXS PHARMAXIS LTD 0.11 29 -45 $43,477,960
DXB DIMERIX LTD 0.6 28 532 $118,649,576
MEM MEMPHASYS LTD 0.135 27 175 $105,556,344
CGS COGSTATE LTD 0.73 27 288 $124,205,968
CYP CYNATA THERAPEUTICS LTD 0.81 25 -52 $92,527,960
PAA PHARMAUST LTD 0.24 24 177 $72,587,096
LCT LIVING CELL TECHNOLOGIES LTD 0.017 21 -23 $9,714,497
OCC ORTHOCELL LTD 0.42 21 8 $79,458,392
ALT ANALYTICA LTD 0.003 20 -25 $10,558,837
RSH RESPIRI LTD 0.155 19 57 $101,190,168
MXC MGC PHARMACEUTICALS LTD 0.026 18 -48 $42,416,840
MDC MEDLAB CLINICAL LTD 0.17 18 -64 $46,146,484
VBS VECTUS BIOSYSTEMS LTD 0.8 18 51 $18,923,852
NYR NYRADA INC-CDI 0.215 16 $23,517,500
AGH ALTHEA GROUP HOLDINGS LTD 0.375 16 -55 $86,324,704
PIQ PROTEOMICS INTERNATIONAL LAB 0.655 15 143 $60,525,848
TLX TELIX PHARMACEUTICALS LTD 1.4 15 9 $368,219,424
NXS NEXT SCIENCE LTD 1.52 14 -45 $268,689,088
SVA SIMAVITA LTD-CDI 0.024 14 100 $27,692,782
AVE AVECHO BIOTECHNOLOGY LTD 0.008 14 100 $12,779,659
VLS VITA LIFE SCIENCES LTD 0.705 14 4 $38,128,240
IDT IDT AUSTRALIA LTD 0.18 13 29 $43,076,344
RNO RHINOMED LTD 0.084 12 -72 $21,319,968
SUD SUDA PHARMACEUTICALS LTD 0.048 12 -50 $14,680,654
IVX INVION LTD 0.01 11 -33 $55,035,988
OIL OPTISCAN IMAGING LTD 0.051 11 21 $24,366,718
NC6 NANOLLOSE LTD 0.053 10 -31 $5,604,750
GLH GLOBAL HEALTH LTD 0.27 10 92 $11,366,546
ONT 1300 SMILES LTD 6.53 10 12 $154,619,840
JHL JAYEX HEALTHCARE LTD 0.033 10 -3 $5,819,980
OSP OSPREY MEDICAL INC-CDI 0.035 10 -45 $50,958,820
ZNO ZOONO GROUP LTD 2.4 10 3378 $392,670,496
SOM SOMNOMED LTD 1.43 9 -16 $118,345,824
M7T MACH7 TECHNOLOGIES LTD 0.98 9 26 $229,689,168
HLA HEALTHIA LTD 0.975 8 3 $61,458,788
SCU STEMCELL UNITED LTD 0.013 8 -19 $8,340,909
NOX NOXOPHARM LTD 0.33 8 -8 $70,369,392
CMP COMPUMEDICS LTD 0.48 8 -34 $83,266,584
MVP MEDICAL DEVELOPMENTS INTERNA 6.65 8 36 $410,146,816
ALC ALCIDION GROUP LTD 0.14 8 -10 $138,697,168
RGS REGENEUS LTD 0.165 8 77 $38,895,500
CAN CANN GROUP LTD 0.49 8 -73 $95,645,336
ICS ICSGLOBAL LTD 1.89 7 122 $20,041,596
VTI VISIONEERING TECH-CDI 0.016 7 -70 $15,509,062
IPD IMPEDIMED LTD 0.08 7 -39 $82,794,344
CYC CYCLOPHARM LTD 1.5 6 11 $120,411,680
BOT BOTANIX PHARMACEUTICALS LTD 0.053 6 -75 $52,525,696
AT1 ATOMO DIAGNOSTICS LTD 0.38 6 $210,404,176
MVF MONASH IVF GROUP LTD 0.555 6 -54 $220,143,680
1AD ADALTA LTD 0.11 6 -7 $24,068,542
IMC IMMURON LTD 0.38 5 259 $88,519,504
IMM IMMUTEP LTD 0.195 5 -9 $97,526,184
PTX PRESCIENT THERAPEUTICS LTD 0.065 5 51 $24,444,158
OSL ONCOSIL MEDICAL LTD 0.115 5 89 $95,289,104
AMT ALLEGRA ORTHOPAEDICS LTD 0.235 4 96 $24,532,246
DVL DORSAVI LTD 0.025 4 -41 $5,554,261
PYC PYC THERAPEUTICS LTD 0.12 4 243 $351,789,344
NSB NEUROSCIENTIFIC BIOPHARMACEU 0.24 4 0 $18,812,300
TD1 TALI DIGITAL LTD 0.027 4 200 $20,231,240
RHT RESONANCE HEALTH LTD 0.145 4 32 $64,347,220
AC8 AUSCANN GROUP HOLDINGS LTD 0.15 3 -59 $47,557,104
ATX AMPLIA THERAPEUTICS LTD 0.15 3 98 $17,945,120
BD1 BARD1 LIFE SCIENCES LTD 0.032 3 10 $76,624,976
ACR ACRUX LTD 0.175 3 -9 $26,986,474
AHX APIAM ANIMAL HEALTH LTD 0.51 3 23 $58,881,552
PGC PARAGON CARE LTD 0.175 3 -61 $59,129,928
CTE CRYOSITE LTD 0.185 3 270 $8,669,019
PBP PROBIOTEC LTD 2.07 2 37 $154,792,256
CAJ CAPITOL HEALTH LTD 0.21 2 -1 $219,858,400
JHC JAPARA HEALTHCARE LTD 0.485 2 -51 $126,942,480
RAC RACE ONCOLOGY LTD 0.9 2 1277 $115,247,896
PAL PALLA PHARMA LTD 0.895 2 -20 $112,723,440
OSX OSTEOPORE LTD 0.61 2 $61,750,608
HCT HOLISTA COLLTECH LTD 0.068 1 19 $18,723,738
SDX SIENNA CANCER DIAGNOSTICS LT 0.07 1 17
ICR INTELICARE HOLDINGS LTD 0.38 1 $27,701,888
PSQ PACIFIC SMILES GROUP LTD 1.45 1 21 $222,597,552
ACW ACTINOGEN MEDICAL LTD 0.026 0 213 $27,905,784
RAP RESAPP HEALTH LTD 0.135 0 -10 $105,716,728
BXN BIOXYNE LTD 0.011 0 -42 $7,041,600
ANP ANTISENSE THERAPEUTICS LTD 0.078 0 54 $39,119,052
EYE NOVA EYE MEDICAL LTD 0.31 0 12 $44,516,352
NEU NEUREN PHARMACEUTICALS LTD 1.3 0 -3 $152,890,544
PAB PATRYS LTD 0.013 0 -43 $18,591,574
IMU IMUGENE LTD 0.056 0 162 $246,557,440
GTG GENETIC TECHNOLOGIES LTD 0.0095 0 168 $82,617,264
EXL ELIXINOL GLOBAL LTD 0.165 0 -92 $31,818,116
ADR ADHERIUM LTD 0.03 0 58 $19,944,358
BWX BWX LTD 4.145 0 82 $580,503,040
VHT VOLPARA HEALTH TECHNOLOGIES 1.37 0 -4 $332,881,024
RCE RECCE PHARMACEUTICALS LTD 1.29 -1 502 $186,698,592
OPT OPTHEA LTD 2.45 -1 -8 $654,053,376
OVN OVENTUS MEDICAL LTD 0.265 -2 -41 $41,939,540
MDR MEDADVISOR LTD 0.485 -2 46 $118,424,656
MMJ MMJ GROUP HOLDINGS LTD 0.095 -2 -61 $21,845,628
PNV POLYNOVO LTD 2.205 -2 50 $1,474,226,304
ARX AROA BIOSURGERY LTD 1.4 -2 $417,104,192
SDI SDI LTD 0.68 -3 -3 $80,828,560
MEB MEDIBIO LTD 0.011 -4 -21 $15,498,119
UCM USCOM LTD 0.205 -5 105 $30,714,808
BIT BIOTRON LTD 0.1 -5 37 $70,193,272
ESE ESENSE-LAB LTD-CDI 0.018 -5 -31 $9,180,684
FFC FARMAFORCE LTD 0.052 -5 -65 $6,696,091
1ST 1ST GROUP LTD 0.035 -6 -56 $14,436,975
ADO ANTEOTECH LTD 0.052 -6 301 $85,380,048
LBT LBT INNOVATIONS LTD 0.145 -6 41 $41,806,376
THC THC GLOBAL GROUP LTD 0.255 -7 -41 $44,152,908
IHL INCANNEX HEALTHCARE LTD 0.064 -8 -25 $46,876,668
CDY CELLMID LTD 0.11 -8 -48 $13,777,155
ZLD ZELIRA THERAPEUTICS LTD 0.054 -8 -18 $61,683,444
PAR PARADIGM BIOPHARMACEUTICALS 2.72 -9 91 $624,145,984
AZV AZURE HEALTHCARE LTD 0.07 -9 -12 $19,893,226
GSS GENETIC SIGNATURES LTD 2.24 -9 110 $328,005,280
S66 STAR COMBO PHARMA LTD 0.33 -10 -42 $44,753,480
LSH LIFESPOT HEALTH LTD 0.036 -10 -47 $3,516,246
MX1 MICRO-X LTD 0.16 -11 -45 $57,146,856
APH AUSTRALIAN PRIMARY HEMP LTD 0.14 -13 -36 $9,765,719
CP1 CANNPAL ANIMAL THERAPEUTICS 0.115 -18 -32 $10,709,375
PCK PAINCHEK LTD 0.11 -21 -41 $123,948,528
ONE ONEVIEW HEALTHCARE PLC-CDI 0.052 -33 -74 $9,006,997
GMV G MEDICAL INNOVATION HOLDING 0.042 -33 -65 $35,230,928

 

While the numbers weren’t high — let’s face it, small caps are capable of much more than a piddly 67 per cent rise in a fortnight — there were a lot of them in positive territory.

Not only have the health and life sciences players been delivering good news generally, but they’re also proving to be a good source of annual results.

But this fortnight, there’s been little rhyme or reason for the large scale upwards moves except that people are buying life sciences stocks.

Factor Therapeutics (ASX:FTT) investors were still buzzing about the company’s transformation into an animal imaging outfit, after that clinical trial which led to a near wipe out of the company’s value.

And clearly news leaked before Neurotech International (ASX:NTI) was able to go into a trading halt. It is still in the process of working out what to tell the ASX and how to release results of lab testing of its cannabis strains.

Imagion Biosystems (ASX:IBX) was all innocence last week when asked why its stock was rising so fast. One theory could be latecomers discovering the Imagion-tesla link.

While other companies may prefer to stay mum on why their stock is moving, BPH Energy (ASX:BPH) is one entity that always has an answer.

In this case the company claimed it was the non-life sciences arm doing the heavy lifting: “BPH notes that the National Offshore Petroleum Titles Administrator (NOPTA) has confirmed on its website that the application currently made by the Joint Venture Participants BUY and BPH for a suspension, variation and extension to the permit terms for PEP11 is in the final phase of decision process and is now with the Joint Authority for decision.”

With a bird flu outbreak underway in Victoria (factory farmed chickens aren’t great at social distancing), Anatara Lifesciences (ASX:ANR) was looking for partners to trial its necrotic enteritis, or chicken gastro, treatment.

It has since done a deal with the University of New England’s Poultry Hub Australia.

Coming in at #13 in the Check Up rankings is Pharmaxis (ASX:PXS), which actually had news that investors could (and were) buying into.

The Food and Drug Administration (FDA) completed a safety review of the company’s Investigational New Drug (IND) application for its pan‐LOX inhibitor PXS‐5505 and gave permission to proceed with a phase 1/2 clinical trial for treating myelofibrosis in adults.

The study is planned to start in the December quarter and expected to conclude in 2022.

And finally sperm separator Memphasys (ASX:MEM) has done a collaboration with Newcastle University to develop new products in niche reproductive biology applications.

With the Felix device on track for commercialisation later this year, Memphasys is now looking to extend its pipeline of products into diagnostics for animal fertility and semen oxidative stress, and development of long life sperm storage media.